Author

M. A. Zelazowska

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

K. M. McBride· 2 shared A. Chikhalya· 1 shared B. Liu· 1 shared B. Sheridan· 1 shared C. H. Hogan· 1 shared C. Khairallah· 1 shared G. V. Reynoso· 1 shared H. D. Hickman· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

K. M. McBride

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

B cell-intrinsic STAT3-mediated support of latency and interferon suppression during murine gammaherpesvirus 68 infection revealed through an in vivo competition model

C. H. Hogan, S. M. Owens, G. V. Reynoso, V. Kirillov, T. J. Meyer, M. A. Zelazowska, B. Liu, X. Li, A. Chikhalya, Q. Dong, C. Khairallah, N. C. Reich, B. Sheridan, K. M. McBride, P. Hearing, , L. T. Krug

This study shows that B cell-intrinsic STAT3 supports gammaherpesvirus latency and suppresses interferon responses in mice, using a competitive infection model.

bioRxiv · Mar 22, 2023 · PreprintMicrobiology

The Longitudinal Analysis of Convergent Antibody VDJ Regions in SARS-CoV-2 Positive Patients Using RNA-seq

K. J. Liu, M. A. Zelazowska, K. M. McBride

This study analyzes longitudinal RNA-seq data from SARS-CoV-2 positive and negative patients to identify convergent antibody VDJ sequences and their antigenic specificity across pandemic stages.

bioRxiv · Nov 2, 2022 · PreprintImmunology